Warning Letter Roundup & Recap – April 21, 2015
This article was originally published in The Gray Sheet
FDA wasn't notified after Thermedx made 21 software upgrades to devices in the field; manufacturer of air filters and spirometers failed to analyze quality data; and more. Six device warning letters were listed by FDA this week.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.